swine
transmiss
gastroenter
acut
rapidli
spread
highli
contagi
enter
diseas
pig
age
character
vomit
wateri
yellow
diarrhea
weight
loss
rapid
dehydr
lead
high
mortal
rate
especi
piglet
mortal
decreas
age
swine
transmiss
gastroenter
caus
transmiss
gastroenter
viru
tgev
genu
coronaviru
famili
coronavirida
major
rout
viru
transmiss
infect
anim
digest
food
properli
die
dehydr
diseas
caus
great
econom
loss
pig
farm
world
primari
mean
anim
protect
vaccin
cheng
niu
straw
et
al
therefor
develop
new
vaccin
implement
largescal
vaccin
program
import
pig
breed
moxley
olson
sever
countri
vaccin
swine
transmiss
gastroenter
conduct
effect
inactiv
monoval
combin
vaccin
recogn
intern
tradit
inactiv
vaccin
high
content
contamin
substanc
caus
side
effect
andor
may
contain
inactiv
compound
toxic
agent
phenol
formaldehyd
normal
use
inactiv
microbi
cell
moreov
tradit
vaccin
usual
low
immunogen
kill
microorgan
induc
fulli
function
cellular
immun
therefor
need
develop
new
effect
less
costli
vaccin
swine
transmiss
gastroenter
mout
et
al
recent
year
seen
extrem
fast
develop
new
viral
nanovaccin
diagnost
agent
use
nanostructur
prepar
biolog
chemic
synthesi
particular
attribut
develop
biocompat
inorgan
nanoparticl
gold
nanoparticl
stabl
metal
nanoparticl
excel
surfac
function
chemistri
high
biocompat
nil
toxic
addit
gold
nanoparticl
easili
synthes
give
shape
sphere
rod
cube
star
pyramid
sever
report
describ
develop
use
nanostructur
deliveri
biolog
activ
agent
target
cell
mout
et
al
bhattacharya
mukherje
staroverov
et
al
reach
target
cell
vivo
nanoparticl
must
bypass
mani
barrier
protect
anim
antigen
dreaden
et
al
gold
nanoparticl
gnp
use
wide
carrier
antigen
therapeut
agent
human
medicin
veterinari
practic
biolog
dykman
khlebtsov
particular
interest
abil
gnp
induc
humor
immun
respons
weakli
immunogen
antigen
hapten
dykman
et
al
dykman
et
al
moreov
gnp
conjug
tgev
immunostimulatori
effect
dykman
et
al
studi
immunolog
variabl
morpholog
chang
immun
organ
guinea
pig
immun
tgev
antigen
conjug
gnp
nanocarri
tgev
strain
taken
museum
strain
laboratori
virolog
scientif
research
veterinari
institut
russian
academi
scienc
saratov
deposit
allrussian
state
collect
microbi
strain
use
veterinari
anim
husbandri
number
patent
tgev
strain
titer
lg
use
test
cultur
inocul
strain
lg
h
cultiv
tgev
purifi
sucros
gradient
accord
horzinek
et
al
result
viru
suspens
use
protein
analysi
sodium
dodecyl
gel
electrophoresi
constant
voltag
v
min
v
h
maniati
et
al
molecular
mass
determin
precis
plu
prestain
protein
standard
use
result
protein
separ
process
gelimag
gel
explor
version
program
dnatechnolog
moscow
genom
ident
check
polymeras
chain
reaction
pcr
use
specif
conserv
part
tgev
genom
contain
base
pair
bp
herrington
mcgee
rna
isol
tgev
use
nucleostm
suspens
silic
sorbent
biokom
moscow
accord
manufactur
instruct
pcr
result
record
transillumin
dnaanalyz
video
system
pcr
product
obtain
prepar
tgev
strain
analyz
electrophoresi
agaros
gel
use
dna
ladder
molecular
size
marker
dna
bacteriophag
neg
control
viral
nucleic
acid
respons
virul
inactiv
isol
tgev
purifi
ribonucleas
rnaas
hydrolas
enzym
catalyz
rna
hydrolysi
inactiv
done
procedur
describ
fedorova
et
al
antigen
result
nucleic
acid
inactiv
use
anim
immun
spheric
gold
nanospher
averag
diamet
nm
made
citrat
method
fren
reduct
ml
aqueou
tetrachloroaur
acid
heat
reflux
magnet
stirrer
erlenmey
flask
follow
addit
ml
aqueou
sodium
citrat
flask
particl
diamet
found
describ
earlier
khlebtsov
dykman
use
libra
transmiss
electron
microscop
carl
zeiss
germani
specord
spectrophotomet
analytik
jena
germani
zetas
nanoz
particl
size
zeta
potenti
analyz
malvern
prepar
nanoparticl
conjug
found
gold
number
minim
amount
antigen
protect
sol
salt
aggreg
antigen
solut
end
antigen
solut
pb
initi
concentr
mg
titrat
twofold
microtit
plate
well
receiv
gnp
nacl
minim
stabil
concentr
antigen
conjug
done
simpl
mix
without
use
coupl
agent
dykman
et
al
thirti
six
male
guinea
pig
weigh
g
time
experi
start
use
anim
care
handl
complianc
guid
care
use
laboratori
anim
european
convent
protect
vertebr
anim
use
experiment
scientif
purpos
legisl
russian
feder
immunobiolog
studi
guinea
pig
divid
four
group
nine
anim
immun
subcutan
along
spinal
column
two
inject
interv
day
guinea
pig
group
inject
ml
tgev
antigen
concentr
per
anim
group
receiv
ml
tgev
antigen
solut
per
anim
group
serv
control
receiv
ml
physiolog
salin
group
serv
control
gnp
receiv
ml
gnp
solut
gnpantigen
group
comparison
group
receiv
physiolog
salin
control
group
anim
kill
day
last
inject
blood
serum
sampl
taken
immunolog
studi
immedi
remov
piec
tissu
organ
place
fix
solut
aqueou
neutral
formalin
histolog
section
prepar
freez
microtom
model
reichert
wien
austria
histolog
sampl
stain
isol
periton
macrophag
anim
kill
fix
back
incis
made
along
midlin
anterior
abdomin
wall
skin
flap
care
separ
care
taken
keep
peritoneum
intact
punctur
made
needl
connect
syring
ml
pb
ph
inject
periton
caviti
anterior
abdomin
wall
gentli
massag
min
periton
fluid
collect
pasteur
pipet
cut
made
peritoneum
filter
test
tube
nylon
filter
cell
wash
three
time
centrifug
pb
g
resuspend
ml
pb
count
goryaev
chamber
periton
macrophag
cultur
standard
procedur
leiter
isol
splenic
lymphocyt
incis
made
along
white
line
peritoneum
periton
macrophag
isol
spleen
remov
spleen
minc
scissor
tissu
piec
mash
fine
siev
petri
plate
contain
steril
pb
result
suspens
subject
densitygradi
centrifug
lymphocyt
ring
collect
new
test
tube
lymphocyt
wash
three
time
centrifug
pb
ph
g
min
cell
sediment
resuspend
ml
pb
lymphocyt
cell
count
haemascreenvet
hematolog
analyz
hospitex
diagnost
itali
titer
antibodi
sera
estim
enzymelink
immunosorb
assay
elisa
horseradish
peroxidaselabel
antibodi
guinea
pig
igg
jackson
immunoresearch
uk
synthet
peptid
use
immobil
antigen
reaction
result
record
plate
screen
micropl
spectrophotomet
interleukin
concentr
sera
measur
plate
screen
analyz
hospitex
diagnost
itali
use
reagent
vectorbest
russia
respiratori
activ
measur
convent
berna
dobrucki
abil
cell
reduc
nitrotetrazolium
blue
tetrazolium
bromid
mtt
formazan
briefli
suspens
known
concentr
isol
anim
cell
macrophag
lymphocyt
centrifug
g
min
sediment
resuspend
ml
mtt
incub
h
incub
cell
centrifug
g
min
sediment
resuspend
ml
dimethyl
sulfoxid
fluka
switzerland
amount
reduc
formazan
measur
genesi
spectrophotomet
nm
construct
calibr
curv
use
commerci
formazan
mg
studi
possibl
morpholog
chang
spleen
import
part
macrophag
system
anim
immun
tgev
control
group
compris
nonimmun
anim
use
spleen
guinea
pig
physiolog
age
longitudin
transvers
spleen
section
prepar
freez
microtom
model
reichert
wien
austria
follow
standard
procedur
histolog
section
differenti
stain
result
statist
process
standard
procedur
use
student
test
evalu
reliabl
differ
sampl
experiment
control
studi
arithmet
mean
standard
deviat
given
data
sampl
found
determin
standard
error
arithmet
mean
confid
limit
student
coeffici
n
p
signific
level
p
obtain
result
statist
process
standard
procedur
integr
excel
softwar
microsoft
corp
usa
arithmet
mean
standard
deviat
given
data
sampl
found
determin
standard
error
arithmet
mean
confid
limit
account
student
coeffici
n
p
number
measur
n
signific
level
p
result
present
histogram
signific
differ
individu
sampl
evalu
twosampl
unpair
student
test
unequ
varianc
differ
consid
signific
experiment
found
pexp
valu
reliabl
chang
record
result
experi
describ
entir
set
antigen
formul
examin
assess
oneway
analysi
varianc
anova
use
fisher
ratio
test
depend
found
consid
signific
f
fcrit
critic
valu
fcrit
n
number
data
set
correspond
p
number
degre
freedom
df
lie
effect
valu
peff
swine
transmiss
gastroenter
caus
rna
viru
belong
group
genu
alphacoronaviru
famili
coronavirida
virion
spheric
shape
diamet
nm
martin
et
al
viral
nucleocapsid
flexibl
spiral
contain
singlestrand
rna
larg
number
nucleocapsid
protein
molecul
delma
et
al
sturman
et
al
viru
replic
cytoplasm
matur
epitheli
cell
locat
end
intestin
villi
gener
scheme
experi
depict
fig
antigen
isol
protein
composit
analyz
found
molecular
mass
separ
protein
ident
tgev
protein
antigen
contain
follow
protein
p
protein
larg
surfac
glycoprotein
molecular
mass
kda
n
protein
basic
nucleocapsid
protein
kda
protein
matrix
membran
protein
kda
fig
protein
fraction
kda
also
present
accord
wesley
et
al
kda
size
unglyc
structur
protein
tgev
thu
known
tgev
protein
separ
tgev
nucleic
acid
identifi
pcr
use
specif
conserv
part
tgev
genom
contain
bp
analysi
pcr
product
purifi
prepar
tgev
strain
done
agaros
gel
electrophoresi
dna
ladder
demonstr
suffici
high
separ
cdna
fig
presenc
characterist
cdna
fraction
size
bp
indic
presenc
tgev
genom
sampl
viru
nucleic
acid
inactiv
ribonucleas
result
antigen
mixtur
viral
capsid
protein
use
conjug
gnp
subsequ
anim
immun
gnp
diamet
measur
tem
averag
particl
size
nm
analysi
antibodi
titer
data
show
titer
produc
immun
conjug
p
higher
produc
immun
unconjug
tgev
antigen
immunolog
mononuclear
phagocyt
system
mp
also
known
previous
reticuloendotheli
macrophag
system
part
immun
system
consist
phagocyt
cell
locat
reticular
connect
tissu
cell
primarili
monocyt
macrophag
accumul
lymph
node
spleen
effect
interact
conjug
cell
reticuloendotheli
system
evalu
use
mtt
test
day
immun
increas
respiratori
activ
macrophag
note
fig
immun
gnpantigen
conjug
activ
increas
p
compar
control
compar
immun
tgev
antigen
compar
gnp
studi
respiratori
activ
splenic
lymphoid
cell
fig
show
immun
conjug
activ
increas
compar
control
wherea
immun
tgev
antigen
alon
chang
much
data
demonstr
immun
anim
tgev
activ
antigenpres
cell
also
increas
prolif
activ
splenic
lymphoid
antibodyform
cell
indic
gnp
present
antigen
organ
endotheli
system
effect
conjug
humor
immun
assess
compar
chang
cytokin
concentr
control
experiment
anim
statist
signific
increas
content
anim
immun
gnpantigen
conjug
fig
anim
highest
content
p
group
comparison
group
receiv
physiolog
salin
control
group
determin
p
valu
error
probabl
deviat
null
hypothesi
error
first
kind
determin
research
p
anim
given
nativ
antigen
gnp
appreci
chang
content
found
content
anim
immun
gnpantigen
conjug
p
higher
intact
anim
anim
given
antigen
alon
p
gnp
p
fig
p
valu
gnpantigen
group
comparison
group
receiv
physiolog
salin
control
group
gnpantigen
group
comparison
group
receiv
physiolog
salin
control
group
increas
concentr
immun
anim
directli
correl
activ
macrophag
stimul
b
cell
produc
cytokin
activ
point
import
sinc
desir
avoid
inflammatori
process
immun
result
appear
granuloma
similar
data
obtain
fig
fact
indic
inject
prepar
stimulatori
cellular
immun
known
interferon
possess
protect
properti
produc
bodi
viru
enter
tumor
diseas
analysi
effect
immun
help
gold
nanoparticl
chang
level
interferon
made
found
immun
group
concentr
interferon
increas
compar
control
group
immun
antigen
immun
anim
nativ
antigen
signific
chang
concentr
interferon
blood
serum
immun
anim
observ
thu
increas
concentr
interferon
indic
stimul
introduc
drug
cell
link
immun
result
obtain
correl
research
area
scientist
exampl
work
zhang
et
al
show
tgev
n
protein
induc
er
stress
activ
respons
upregul
express
tao
et
al
also
reveal
increas
concentr
cytokin
includ
interferon
gamma
interleukin
respons
immun
scpg
mainli
consid
reaction
splenocyt
given
complex
reaction
express
product
cytokin
effect
aunp
studi
addit
administ
togeth
scpg
strong
immunomodul
interest
us
look
product
cytokin
bodi
whole
reveal
gener
clinic
chang
develop
introduct
antigen
aunp
one
specul
gnp
facilit
antigen
express
major
histocomp
complex
surfac
antigenpres
cell
subsequ
ensur
viral
peptid
effect
present
cytotox
lymphocyt
natur
killer
data
increas
activ
agreement
increas
respiratori
activ
splenocyt
day
last
inject
anoth
indic
colloid
gold
stimul
releas
cell
therebi
enhanc
activ
lymphoid
immun
guinea
pig
spleen
form
leucocyt
remov
old
red
blood
cell
erythrocyt
spleen
framework
form
trabecula
consist
reticular
connect
tissu
smooth
muscl
cell
blood
vessel
time
spleen
contain
effer
lymphat
vessel
reticular
connect
tissu
includ
red
white
pulp
white
pulp
lymphoid
tissu
produc
immun
blood
cell
red
pulp
function
filter
blood
antigen
microorgan
defect
red
blood
cell
therefor
contain
variou
blood
corpuscl
includ
larg
small
lymphocyt
immatur
leucocyt
leucocyt
final
stage
graini
disintegr
erythrocyt
spleen
also
import
develop
humor
immun
bsystem
organ
anim
immun
gnpantigen
conjug
lymphoid
follicl
distinct
boundari
contain
larg
number
dens
space
lymphoid
cell
fig
lymphoid
tissu
well
structur
locat
compact
manner
clear
boundari
red
white
pulp
region
full
cellular
element
comparison
analyz
morpholog
chang
spleen
anim
immun
tgev
antigen
alon
observ
chang
character
exist
perivascular
edema
fig
sometim
accompani
prolifer
desquam
vessel
endothelium
moreov
lymphoid
tissu
follicl
becam
spars
number
densiti
lymphoid
cell
decreas
spleen
tissu
section
anim
immun
tgev
antigen
alon
boundari
red
white
pulp
less
clear
size
total
number
follicl
microscop
field
decreas
germin
center
could
detect
result
point
degrad
process
immun
organ
anim
control
group
guinea
pig
gnp
inject
physiolog
salin
morpholog
chang
spleen
tissu
observ
fig
b
gold
nanoparticl
stabl
metal
nanoparticl
excel
surfac
function
chemistri
high
biocompat
nil
toxic
pissuwan
et
al
addit
gold
nanoparticl
easili
synthes
give
shape
sphere
rod
cube
star
pyramid
qualiti
allow
use
gold
nanoparticl
varieti
purpos
includ
vaccin
deliveri
versiani
et
al
seri
work
devot
use
gold
nanoparticl
carrier
antigen
pathogen
viru
gripp
tao
et
al
viru
footandmouth
chen
et
al
tetanu
toxoid
barhat
et
al
yersinia
pesti
gregori
et
al
work
use
spheric
gold
nanoparticl
averag
diamet
nm
platform
antigen
tgev
data
demonstr
immun
anim
tgev
activ
antigenpres
cell
also
increas
prolif
activ
splenic
lymphoid
antibodyform
cell
content
anim
immun
gnpantigen
conjug
higher
intact
anim
anim
given
antigen
alon
increas
concentr
immun
anim
directli
correl
activ
macrophag
stimul
b
cell
produc
cytokin
activ
increas
concentr
indic
inject
prepar
stimulatori
cellular
immun
sever
report
describ
develop
use
nanostructur
stimul
cellular
immun
exampl
xu
et
al
show
gold
nanorod
associ
dna
vaccin
may
caus
increas
format
hivinfect
mice
assi
et
al
show
gold
nanorod
function
cysteamin
associ
protein
stimulatori
work
tao
et
al
show
use
nanostructur
vaccin
led
increas
concentr
iga
tnf
rant
research
correl
studi
present
work
use
gold
nanoparticl
first
time
platform
antigen
tgev
also
nonspecif
adsorpt
antigen
perform
chemic
surfac
function
made
possibl
simplifi
conjug
process
well
remov
addit
procedur
relat
purif
drug
toxic
compon
addit
analyz
morpholog
chang
spleen
anim
immun
gnpantigen
conjug
tgev
antigen
microanatom
chang
increas
number
follicl
indic
activ
bdepend
zone
spleen
consequ
develop
humoraltyp
immunolog
reaction
galaktionov
degrad
process
observ
anim
immun
tgev
antigen
alon
evid
weak
resist
pathogen
attack
conclus
immun
tgev
antigen
conjug
gnp
carrier
activ
respiratori
activ
lymphoid
cell
periton
macrophag
directli
relat
transform
activ
activ
antibodi
gener
furthermor
use
conjug
allow
mark
improv
structur
anim
immun
organ
restor
state
organ
result
studi
use
develop
nanovaccin
swine
transmiss
gastroenter
microanatom
chang
increas
number
follicl
indic
activ
bdepend
zone
spleen
consequ
develop
humoraltyp
immunolog
reaction
galaktionov
degrad
process
observ
anim
immun
tgev
antigen
alon
evid
weak
resist
pathogen
attack
